DELRAY BEACH, Fla., Oct. 11, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its E-N-G Mobile Systems, Inc. (“ENG”) subsidiary, a specialty vehicle manufacturer, is celebrating 40 years in business.

ENG got its start in 1977 as a provider of electronic news gathering vehicles in Oakland, California. Soon after its formation, ENG began selling vehicles throughout the country as it became known for building quality vehicles that allowed broadcasters to respond to the increasing need for mobile television news.
As business opportunities evolved, ENG broadened its product line to include vehicles for mobile laboratory, wireless/cellular infrastructure, communications, utilities, and other technical applications. ENG was the first vehicle manufacturer to install a gas chromatography mass spectrometry in a mobile laboratory, which design became the basis for its successful MobiLab™ line of mobile laboratories. ENG has delivered more than 400 MobiLab vehicles and more than 1,500 vehicles total to customers around the world.

“We are very proud of ENG’s 40 years in business, during which time the ENG team has worked to build a strong reputation for reliability, customer service and innovative design,” stated William J. Caragol, Chairman and CEO of PositiveID. “Through ENG’s decades-long track record of engineering and technical expertise it has become a leader in the diverse specialty vehicle industry.”

ENG, which has a video on its website showcasing its capabilities, designs and builds mobile laboratories, wireless support vehicles (cell-on-wheels and cell-on-light-trucks), radio frequency (“RF”) test platforms, custom vehicles for utility companies, broadcast news vehicles, and other technical vehicles. It also offers service and maintenance, including mobile support and repairs on-call or under service contracts to help minimize vehicle downtime.

ENG has delivered more than 1,500 specialty vehicles to customers around the globe, including more than 400 mobile laboratories, 600 broadcast news vehicles, and more than 400 vehicles for cellular, RF, infrared, utilities, and other applications. In June 2017, PositiveID sold a 49.8% equity interest in ENG for approximately $1.5 million to a strategic partner to help grow the worldwide lab business.

About PositiveID Corporation
PositiveID Corporation is a holding company focused on life sciences, diagnostics, mobile laboratories, and medical devices. PositiveID’s ExcitePCR subsidiary is developing the FireflyDX family of pathogen detection systems, portable devices offering rapid sample-to-result detection in less than 30 minutes using real-time polymerase chain reaction chemistry. PositiveID’s E-N-G Mobile Systems™ subsidiary is a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. PositiveID’s Thermomedics™ subsidiary markets the FDA-cleared Caregiver® non-contact thermometer for clinical use. For more information on PositiveID, please visit, or connect with PositiveID on Twitter, Facebook or LinkedIn.

Statements about PositiveID's future expectations, including the likelihood that PositiveID sold a 49.8% equity interest in ENG to a strategic partner to help grow the worldwide lab business; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, PositiveID’s ability to raise capital; PositiveID’s ability to attract and retain customers; as well as other risks. Additional information about these and other factors that could affect PositiveID's business is set forth in its various filings with the Securities and Exchange Commission, including those set forth in its 10-K filed on March 31, 2017, and 10-Qs filed on August 14, 2017, May 15, 2017, and November 18, 2016, under the caption "Risk Factors." PositiveID undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

PositiveID Corporation
Allison Tomek
(561) 805-8044